| 000 | 01154 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513072643.0 | ||
| 264 | 0 | _c19930812 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKloppenburg, M | |
| 245 | 0 | 0 |
_aAntibiotics as disease modifiers in arthritis. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_aS113-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMinocycline _xadverse effects |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aBreedveld, F C | |
| 700 | 1 | _aMiltenburg, A M | |
| 700 | 1 | _aDijkmans, B A | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 11 Suppl 8 _gp. S113-5 |
|
| 999 |
_c8324215 _d8324215 |
||